SKYLIBRARY
Live / Applied — Statement of use — processing complete, to examiner (as of 26 Feb 2026)
What this means for you
Not registered yet, but its 26 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98421561
- Mark type
- Stylized text
- Filed
- 26 Feb 2024
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Peter Kunin
Goods and services
- Class 042 — Scientific and technological services: Providing scientific research and testing services in the field of directed identification and grouping of small molecules with a propensity for the modulation of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases.
Owner
- Skyhawk Therapeutics, Inc., Waltham, MA, US
- Skyhawk Therapeutics, Inc., Waltham, MA, US
Prosecution history
- 27 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Nov 2025 — USE AMENDMENT FILED
- 26 Feb 2026 — SOU EXTENSION 1 GRANTED
- 19 Nov 2025 — SOU EXTENSION 1 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 20 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Feb 2025 — EXAMINERS AMENDMENT E-MAILED